HCA Stock Recent News
HCA LATEST HEADLINES
HCA continues to witness growth in reported and same-facility admissions. The company reaffirms 2025 guidance.
HCA Healthcare, Inc. (NYSE:HCA ) Q1 2025 Earnings Conference Call April 25, 2025 10:00 AM ET Company Participants Frank Morgan - Vice President of Investor Relations Sam Hazen - Chief Executive Officer Mike Marks - Chief Financial Officer Conference Call Participants Ann Hynes - Mizuho Securities Pito Chickering - Deutsche Bank A.J. Rice - UBS Whit Mayo - Leerink Partners Ben Hendrix - RBC Capital Markets Sarah James - Cantor Fitzgerald Brian Tanquilut - Jefferies Andrew Mok - Barclays Capital Matthew Gillmor - KeyBanc Capital Markets Justin Lake - Wolfe Research Joanna Gajuk - Bank of America Ryan Langston - TD Cowen Joshua Raskin - Nephron Research Stephen Baxter - Wells Fargo John Ransom - Raymond James Lance Wilkes - Bernstein Ben Rossi - J.P.
The headline numbers for HCA (HCA) give insight into how the company performed in the quarter ended March 2025, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.
HCA Healthcare (HCA) came out with quarterly earnings of $6.45 per share, beating the Zacks Consensus Estimate of $5.77 per share. This compares to earnings of $5.36 per share a year ago.
HCA Healthcare (HCA 1.64%), a prominent player in the healthcare sector, announced robust first-quarter results for 2025 on Friday, April 25, that surpassed market expectations. The company recorded an adjusted EPS of $6.45 for Q1 2025, exceeding the anticipated $5.75.
Hospital operator HCA Healthcare said on Friday its first-quarter profit rose nearly 9%, as more people underwent elective procedures and sought medical care due to a rise in flu cases.
NASHVILLE, Tenn.--(BUSINESS WIRE)--HCA Healthcare, Inc. (NYSE: HCA) today announced financial and operating results for the first quarter ended March 31, 2025. Key first quarter metrics (all percentage changes compare 1Q 2025 to 1Q 2024 unless otherwise noted): Revenues totaled $18.321 billion Net income attributable to HCA Healthcare, Inc. totaled $1.610 billion, or $6.45 per diluted share Adjusted EBITDA totaled $3.733 billion Cash flows from operating activities totaled $1.651 billion Same f.
The medical sector can provide a defensive hedge against economic uncertainty, and investors may be eyeing AbbVie (ABBV) and HCA Healthcare (HCA) stock ahead of their Q1 reports on Friday, April 25.
HCA's first-quarter earnings are likely to have benefited from growing admissions.
Looking beyond Wall Street's top -and-bottom-line estimate forecasts for HCA (HCA), delve into some of its key metrics to gain a deeper insight into the company's potential performance for the quarter ended March 2025.